These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24192865)

  • 1. First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.
    Hernández L; Gálvez R; Montoya A; Checa R; Bello A; Bosschaerts T; Jansen H; Rupérez C; Fortin A; Miró G
    Parasitol Res; 2014 Jan; 113(1):157-64. PubMed ID: 24192865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
    Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S
    Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of canine leishmaniosis with aminosidine at an optimized dosage regimen: a pilot open clinical trial.
    Athanasiou LV; Saridomichelakis MN; Kontos VI; Spanakos G; Rallis TS
    Vet Parasitol; 2013 Feb; 192(1-3):91-7. PubMed ID: 23140991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.
    Fortin A; Hendrickx S; Yardley V; Cos P; Jansen H; Maes L
    J Antimicrob Chemother; 2012 Nov; 67(11):2707-12. PubMed ID: 22782488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a point-of-care test for the detection of anti-Leishmania infantum antibodies is associated with immunofluorescent antibody titer and clinical stage of leishmaniosis in dogs from endemic regions.
    Davenport K; Liu J; Sarquis J; Beall M; Montoya A; Drexel J; Denis T; Toste R; Traversa D; Miró G
    Vet Parasitol Reg Stud Reports; 2024 Aug; 53():101061. PubMed ID: 39025539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine visceral leishmaniasis: a comparative study of real-time PCR, conventional PCR, and direct agglutination on sera for the detection of Leishmania infantum infection.
    Mohammadiha A; Haghighi A; Mohebali M; Mahdian R; Abadi AR; Zarei Z; Yeganeh F; Kazemi B; Taghipour N; Akhoundi B; Barati M; Mahmoudi MR
    Vet Parasitol; 2013 Feb; 192(1-3):83-90. PubMed ID: 23153824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.
    Manna L; Vitale F; Reale S; Caracappa S; Pavone LM; Morte RD; Cringoli G; Staiano N; Gravino AE
    Vet Parasitol; 2004 Nov; 125(3-4):251-62. PubMed ID: 15482882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
    Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
    Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of experimental infection of canine leishmaniosis: follow-up and utility of noninvasive diagnostic techniques.
    Hernández L; Montoya A; Checa R; Dado D; Gálvez R; Otranto D; Latrofa MS; Baneth G; Miró G
    Vet Parasitol; 2015 Jan; 207(1-2):149-55. PubMed ID: 25692190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
    Fortin A; Caridha DP; Leed S; Ngundam F; Sena J; Bosschaerts T; Parriott S; Hickman MR; Hudson TH; Grogl M
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3144. PubMed ID: 25210745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum.
    Gonçalves G; Campos MP; Gonçalves AS; Figueiredo FB
    Rev Bras Parasitol Vet; 2024; 33(1):e015023. PubMed ID: 38359300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
    Corpas-López V; Merino-Espinosa G; Acedo-Sánchez C; Díaz-Sáez V; Navarro-Moll MC; Morillas-Márquez F; Martín-Sánchez J
    Vet Res Commun; 2018 Jun; 42(2):121-130. PubMed ID: 29453596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
    Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L
    Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of Leishmania spp. in dogs of a subtropical locality of Argentina.
    Ascencio ME; Sarmiento NF; Schnittger L; Florin-Christensen M; Rodriguez AE
    Transbound Emerg Dis; 2020 Jul; 67 Suppl 2():106-110. PubMed ID: 31496050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.